However, except for ovarian and breast cancers, BRCA1/2 germline mutations are less frequently observed in other malignancies, including gastric and pancreatic cancers (5%-10%), melanoma (5%) [62], prostate and NSCLC (1%-2%) [63, 64]. Here, BRCA1 is linked to melanoma.